Cargando…
An institutional audit of the use of novel drugs in pediatric oncology
BACKGROUND: Significant challenges persist in treating children with rare, relapsed, or refractory malignancies. Novel molecularly targeted drugs promise improved outcomes for these children with reduced toxicity. However, there is often limited evidence to substantiate their clinical efficacy and g...
Autores principales: | Lee, Justin, Gillam, Lynn, Kouw, Sarah, McCarthy, Maria C., Hansford, Jordan R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714541/ https://www.ncbi.nlm.nih.gov/pubmed/33939320 http://dx.doi.org/10.1002/cnr2.1404 |
Ejemplares similares
-
Ethical challenges faced by healthcare workers in pediatric oncology care during the COVID‐19 pandemic in Australia
por: Marks, India R., et al.
Publicado: (2022) -
Reinventing the Clinical Audit in a Pediatric Oncology Network
por: Russo, Carolyn, et al.
Publicado: (2023) -
Telling the truth to seriously ill children: Considering children's interests when parents veto telling the truth
por: Gillam, Lynn, et al.
Publicado: (2022) -
Specialist Pediatric Palliative Care Referral Practices in Pediatric Oncology: A Large 5-year Retrospective Audit
por: Ghoshal, Arunangshu, et al.
Publicado: (2016) -
Evaluating the Need for Integrated Pediatric Palliative Care Services in a Pediatric Oncology Setting: A Retrospective Audit
por: Bhat K, Vasudeva, et al.
Publicado: (2021)